B-Cell Acute Lymphoblastic Leukemia clinical trials at UCSD
1 in progress, 0 open to eligible people
Showing trials for
CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)
Sorry, in progress, not accepting new patients
This is a Phase Ib/II study to evaluate the safety and efficacy of autologous T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia (ALL).
La Jolla, California and other locations